These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24598833)

  • 21. Is liver function monitoring warranted during risperidone treatment?
    Landau J; Martin A
    J Am Acad Child Adolesc Psychiatry; 1998 Oct; 37(10):1007-8. PubMed ID: 9785708
    [No Abstract]   [Full Text] [Related]  

  • 22. The role of CYP2D6 and TaqI A polymorphisms in malignant neuroleptic syndrome: two case reports with three episodes.
    Zivković M; Mihaljević-Peles A; Sagud M; Silić A; Mihanović M
    Psychiatr Danub; 2010 Mar; 22(1):112-6. PubMed ID: 20305604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytochrome P450 2D6 deficiency and its clinical relevance in a patient treated with risperidone.
    Köhnke MD; Griese EU; Stösser D; Gaertner I; Barth G
    Pharmacopsychiatry; 2002 May; 35(3):116-8. PubMed ID: 12107857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risperidone rechallenge for marked liver function test abnormalities in an autistic child.
    Copur M; Erdogan A
    Recent Pat Endocr Metab Immune Drug Discov; 2011 Sep; 5(3):237-9. PubMed ID: 21913889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of the CYP2D6*10 alleles and co-medication with CYP2D6-dependent drugs on risperidone metabolism in patients with schizophrenia.
    Yagihashi T; Mizuno M; Chino B; Sato Y; Sakuma K; Takebayashi T; Takao T; Kosaki K
    Hum Psychopharmacol; 2009 Jun; 24(4):301-8. PubMed ID: 19387994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A population pharmacokinetic evaluation of the influence of CYP2D6 genotype on risperidone metabolism in patients with acute episode of schizophrenia.
    Locatelli I; Kastelic M; Koprivsek J; Kores-Plesnicar B; Mrhar A; Dolzan V; Grabnar I
    Eur J Pharm Sci; 2010 Oct; 41(2):289-98. PubMed ID: 20599499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thioridazine inhibits risperidone metabolism: a clinically relevant drug interaction.
    Nakagami T; Yasui-Furukori N; Saito M; Mihara K; De Vries R; Kondo T; Kaneko S
    J Clin Psychopharmacol; 2005 Feb; 25(1):89-91. PubMed ID: 15643105
    [No Abstract]   [Full Text] [Related]  

  • 28. Second-generation thiazolidinediones and hepatotoxicity.
    Marcy TR; Britton ML; Blevins SM
    Ann Pharmacother; 2004 Sep; 38(9):1419-23. PubMed ID: 15266041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risperidone- and quetiapine-induced cholestasis.
    Wright TM; Vandenberg AM
    Ann Pharmacother; 2007 Sep; 41(9):1518-23. PubMed ID: 17666578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A model-based approach to characterize the population pharmacokinetics and the relationship between the pharmacokinetic and safety profiles of RBP-7000, a new, long-acting, sustained-released formulation of risperidone.
    Gomeni R; Heidbreder C; Fudala PJ; Nasser AF
    J Clin Pharmacol; 2013 Oct; 53(10):1010-9. PubMed ID: 23868656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risperidone- and paliperidone-induced hepatotoxicity: Case report and review of literature.
    Khorassani F; Sousonis F; Lopez LV
    Am J Health Syst Pharm; 2020 Sep; 77(19):1578-1584. PubMed ID: 32699878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum prolactin levels, plasma risperidone levels, polymorphism of cytochrome P450 2D6 and clinical response in patients with schizophrenia.
    Wang L; Yu L; Zhang AP; Fang C; Du J; Gu NF; Qin SY; Feng GY; Li XW; Xing QH; He L
    J Psychopharmacol; 2007 Nov; 21(8):837-42. PubMed ID: 17715206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronically administered risperidone did not change the number of hepatocytes in rats: a stereological and histopathological study.
    Halici Z; Keles ON; Unal D; Albayrak M; Suleyman H; Cadirci E; Unal B; Kaplan S
    Basic Clin Pharmacol Toxicol; 2008 May; 102(5):426-32. PubMed ID: 18248514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case study: neuroleptic malignant syndrome with risperidone and CYP2D6 gene variation.
    Ochi S; Kawasoe K; Abe M; Fukuhara R; Sonobe K; Kawabe K; Ueno S
    Gen Hosp Psychiatry; 2011; 33(6):640.e1-2. PubMed ID: 21749835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma pharmacokinetic characteristics of risperidone and their relationship to saliva concentrations in children with psychiatric or neurodevelopmental disorders.
    Aman MG; Vinks AA; Remmerie B; Mannaert E; Ramadan Y; Masty J; Lindsay RL; Malone K
    Clin Ther; 2007 Jul; 29(7):1476-86. PubMed ID: 17825699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A review of liver function tests during treatment with atypical antipsychotic drugs: a chart review study.
    Atasoy N; Erdogan A; Yalug I; Ozturk U; Konuk N; Atik L; Ustundag Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1255-60. PubMed ID: 17600607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relevance of CYP2D6 variability in first-episode schizophrenia patients treated with risperidone.
    Barteček R; Juřica J; Zrůstová J; Kašpárek T; Pindurová E; Žourková A
    Neuro Endocrinol Lett; 2012; 33(2):236-44. PubMed ID: 22592207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CYP2D6 pharmacogenetics and risperidone: reflections after 25 years of research.
    de Leon J; Schoretsanitis G
    Pharmacogenomics; 2020 Nov; 21(16):1139-1144. PubMed ID: 33054667
    [No Abstract]   [Full Text] [Related]  

  • 39. Risperidone-induced hepatotoxicity in a patient addicted to synthetic cannabinoid.
    Saglam O; Bahsi R; Akkoca Y; Filik L
    Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):360-1. PubMed ID: 26825144
    [No Abstract]   [Full Text] [Related]  

  • 40. CYP2D6 poor metabolizer status might be associated with better response to risperidone treatment.
    Almoguera B; Riveiro-Alvarez R; Lopez-Castroman J; Dorado P; Vaquero-Lorenzo C; Fernandez-Piqueras J; Llerena A; Abad-Santos F; Baca-García E; Dal-Ré R; Ayuso C;
    Pharmacogenet Genomics; 2013 Nov; 23(11):627-30. PubMed ID: 24026091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.